Smiths Group PLC
03 February 2006
Smiths Group: current trading
Smiths Group will announce its interim results on Wednesday, 15 March for the
six months ended 31 January 2006. At the start of its close period, the company
is providing the following trading update.
The company is currently achieving strong growth across its activities, and
sales in the first half are expected to be close to 20% higher than a year ago.
Underlying sales are expected to be ahead in all four divisions, with Medical
additionally gaining from the inclusion of Medex for the full period.
Operating profit, after charging restructuring costs, is also expected to have
improved by approximately 20%, sustaining margins of approximately 12% at this
interim stage. As indicated at the AGM, the pattern of profit performance will
vary by division. Double digit growth is expected in Specialty Engineering,
Detection and Medical (the latter helped by the inclusion of Medex). In
Aerospace, profit in this half is expected to be lower than last year, due to
higher development costs expensed in the period.
Higher interest charges, due to the acquisition of Medex, will be partly offset
by an improvement in pensions financing. Profit before tax and EPS are both
expected to be close to 14% ahead of last year.
Net debt at 31 January is expected to be below £1 billion. The conversion of
cash from operating profit should be above 80%, after capital expenditure and
significantly higher development costs capitalised in this period.
Looking ahead, Smiths expects to sustain growth through the second half, with
all four divisions contributing to a strong performance by the company in 2006.
-o-
Media: Investors:
Chris Fox Russell Plumley
+44 (0) 20 8457 8403 +44 (0) 20 8457 8203
chris.fox@smiths-group.com russell.plumley@smiths-group.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.